The Trust is using the world’s first autonomous technology to examine lesions without the need for a dermatology team review.
This allows patients to be discharged on the same day they receive their results.
DERM is the only AI technology approved to make clinical decisions in cancer care and is 97% effective at detecting skin cancer.
